|  | Final analysis set (N = 486) | ||
---|---|---|---|---|
 |  | LS mean | 95 % CI | P value |
Follow-up | 6 months | 0.85 | 0.07–1.63 | – |
 | 12 months | 1.02 | 0.23–1.80 | – |
 | 18 months | 0.13 | −0.69 to 0.95 | – |
 | 24 months | 0.22 | −0.62 to 1.07 | – |
 | 6–12 months | −0.16 | −0.63 to 0.30 | .4849 |
 | 6–18 months | 0.72 | 0.21–1.23 | .0057 |
 | 6– 24 months | 0.63 | 0.05–1.20 | .0323 |
 | 12–18 months | 0.89 | 0.49–1.28 | <.0001 |
 | 12–24 months | 0.79 | 0.27–1.31 | .0029 |
 | 18–24 months | −0.09 | −0.51 to 0.32 | .6622 |
Prior chemotherapies | Yes | 1.75 | 0.90–2.61 | - |
 | No | −0.64 | −1.49 to 0.21 | - |
 | Yes–No | 2.40 | 1.60-3.19 | <.0001 |
Age group | >60 years | 1.30 | 0.39–2.22 | – |
 | ≤60 years | −0.19 | −0.99 to 0.60 | – |
 | >60 to ≤60 years | 1.50 | 0.68–2.32 | .0004 |
Mastectomy | Yes | 0.72 | 0.21–1.24 | – |
 | No | 0.39 | −1.02 to 1.79 | – |
 | Yes–No | 0.33 | −1.16 to 1.83 | .6596 |
Axillary lymph-node dissection | Yes | 0.06 | −0.78 to 0.90 | – |
 | No | 1.05 | 0.10–2.00 | – |
 | Yes–No | −0.99 | −1.97 to −0.01 | .0482 |